Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001992063 | SCV002285187 | uncertain significance | Amyotrophic lateral sclerosis type 1; Perry syndrome; Neuronopathy, distal hereditary motor, type 7B | 2024-07-03 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 985 of the DCTN1 protein (p.Lys985Arg). This variant is present in population databases (rs751782015, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of DCTN1-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 1496799). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DCTN1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV004774600 | SCV005386391 | uncertain significance | not provided | 2024-01-12 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003968677 | SCV004795113 | uncertain significance | DCTN1-related disorder | 2024-02-13 | no assertion criteria provided | clinical testing | The DCTN1 c.2954A>G variant is predicted to result in the amino acid substitution p.Lys985Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0044% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |